A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
Condition:   Obesity Interventions:   Drug: LY3437943;   Drug: Midazolam;   Drug: Warfarin;   Drug: Caffeine Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2022 Category: Research Source Type: clinical trials